NCT07191223 Evaluation of Knowledge on Tick-borne Encephalitis Virus (TBEV) Infection Among General Practitioners in France
| NCT ID | NCT07191223 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Strasbourg, France |
| Condition | Tick-borne Encephalitis, France |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-02-16 |
| Primary Completion | 2026-02-16 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2024-02-16 with a primary completion date of 2026-02-16.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Tick-borne encephalitis is a relatively rare disease (approximately 35 cases diagnosed per year), but most cases (86%) are due to contamination in France via a tick bite. Of the 71 cases reported over two years (May 2021 to May 2023), 94% of patients were hospitalized. It is therefore important to consider and diagnose at the first signs to ensure appropriate follow-up and also to implement primary prevention in endemic/at-risk areas.
Eligibility Criteria
Inclusion Criteria: * Be a doctoral student or in training * Practice in France * Agree to participate in the survey. Exclusion Criteria: \- Refusal to participate in the study
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07191223 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Tick-borne Encephalitis, France. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07191223 currently recruiting?
Yes, NCT07191223 is actively recruiting participants. Contact the research team at yves.hansmann@chru-strasbourg.fr for enrollment information.
Where is the NCT07191223 trial being conducted?
This trial is being conducted at Strasbourg, France.
Who is sponsoring the NCT07191223 clinical trial?
NCT07191223 is sponsored by University Hospital, Strasbourg, France. The trial plans to enroll 100 participants.